YAZ, Yasmin, and Ocella

TWO RECENT STUDIES FIND INCREASED RISK FROM YAZ

Recently the British Medical Journal published two studies which greatly strengthen the proof that Yaz causes more blood clots than other birth control pills. The first was a study of women using oral contraceptives in the United States. It revealed that 2.8 times as many women using birth control pills with drospirenone as compared with women using birth control pills with the active ingredient levonorgestrel (not contained in Yaz) had a non-fatal thromboembolism. A second study looking at the United Kingdom general practice research database revealed an almost identical 2.7 incidence ratio.

Both Yaz and Yasmin contain the controversial synthetic progestin, drospirenone. Ocella is the generic version of Yasmin. Yasmin and Yaz are third generation birth control pills marketed by Bayer Healthcare. Both birth control pills are different from other third generation combined hormonal birth control pills in that they contain drospirenone, a progestin that is unlike other progestins available in the United States. Pills containing drospirenone were never marketed in the United States before Bayer introduced Yasmin in April 2001, followed by Yaz in 2006.

Over 50 reports of Yasmin or Yaz deaths were reported to the FDA between the first quarter of 2004 and the third quarter of 2008 according to published accounts. The deaths involved women as young as 17 and included cardiac arrests, pulmonary embolisms and strokes, with elevated levels of potassium in the blood frequently reported as the cause of these health-related tragedies.

The FDA has warned that advertising for Yasmin and Yaz are misleading and minimize important risk information.

Studies have confirmed the increased risk of Yasmin and Yaz compared to other birth control pills. Oral contraceptives containing drospirenone are associated with a significantly increased risk of venous thrombosis (blood clots) compared with oral contraceptives containing another common progestogen, Levonorgestrel.

The Most Serious Yasmin, Yaz and Ocella Side Effects Include:

  • Blood Clots
  • Stroke (clot in the brain)
  • Pulmonary Embolism (clot in the lung)
  • Cardiac Arrest (clot in the heart)
  • Deep Vein Thrombosis or “DVT” (A DVT is clot in a deep vein, the largest veins in the body. If a clot blocks a deep vein, it is usually life threatening)
  • Gallbladder Problems
  • Kidney Problems

If you or a loved one used Yaz, Yasmin or Ocella, and suffered from any of the injuries mentioned or other side effects associated with this product, you may have a claim.

Have a Question?

Please Contact Us using our Contact page
or by calling Toll-Free: (800) 664-1734

Recent Posts about Drugs and Pharmaceuticals

URGENT RECALL: BRAVELLE® FOLLICLE-STIMULATING HORMONE RECALLED FOR LACK OF EFFICACY

URGENT RECALL: BRAVELLE® FOLLICLE-STIMULATING HORMONE RECALLED FOR LACK OF EFFICACY

URGENT RECALL: BRAVELLE® FOLLICLE-STIMULATING HORMONE RECALLED FOR LACK OF EFFICACY In October[...]
Federal Judge Confirms $200 Million Settlement for Victims Injured by Tainted NECC Steroids

Federal Judge Confirms $200 Million Settlement for Victims Injured by Tainted NECC Steroids

Springfield, Mass. - Yesterday, Federal Bankruptcy Judge Henry Boroff ruled in open court confirming[...]
Federal Jury Awards over $9 Billion in Actos Trial

Federal Jury Awards over $9 Billion in Actos Trial

On Monday, a jury in Louisiana awarded Terrence and Susan Allen over $9 Billion (that’s right: $9,[...]
No thumbnail available

FDA Uncovers Wide-Spread Contamination in Weight Loss Products

The FDA has launched an investigation of weight loss products contaminated with undeclared chemica[...]
No thumbnail available

Male Testosterone Supplements Linked to Increased Risk of Heart Attack & Stroke

Abbott Labs is under fire after several users of its Androgel® testosterone replacement drug cla[...]
Unexpected Breast Growth from Risperdal Traumatizes Young Men

Unexpected Breast Growth from Risperdal Traumatizes Young Men

Just before the first trial involving Risperdal® (Risperidone) began in Pennsylvania state court[...]
Andrews Thornton Higgins Razmara Investigates ADHD Medications Linked to Priapism in Men

Andrews Thornton Higgins Razmara Investigates ADHD Medications Linked to Priapism in Men

The FDA warns that a class of medications used to treat attention deficit hyperactivity disorder (AD[...]
No thumbnail available

Andrews Thornton Higgins Razmara Hand-Delivers NECC Bankruptcy Claims

In order to guarantee proper and timely filing of over 150 claims in the New England Compounding[...]